Cargando…

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern

Effective vaccines protect individuals by not only reducing the susceptibility to infection, but also reducing the infectiousness of breakthrough infections in vaccinated cases. To disentangle the vaccine effectiveness against susceptibility to infection (VE(S)) and vaccine effectiveness against inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyngse, Frederik Plesner, Mølbak, Kåre, Denwood, Matt, Christiansen, Lasse Engbo, Møller, Camilla Holten, Rasmussen, Morten, Cohen, Arieh Sierra, Stegger, Marc, Fonager, Jannik, Sieber, Raphael Niklaus, Ellegaard, Kirsten Maren, Nielsen, Claus, Kirkeby, Carsten Thure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244879/
https://www.ncbi.nlm.nih.gov/pubmed/35773247
http://dx.doi.org/10.1038/s41467-022-31494-y
Descripción
Sumario:Effective vaccines protect individuals by not only reducing the susceptibility to infection, but also reducing the infectiousness of breakthrough infections in vaccinated cases. To disentangle the vaccine effectiveness against susceptibility to infection (VE(S)) and vaccine effectiveness against infectiousness (VE(I)), we took advantage of Danish national data comprising 24,693 households with a primary case of SARS-CoV-2 infection (Delta Variant of Concern, 2021) including 53,584 household contacts. In this setting, we estimated VE(S) as 61% (95%-CI: 59-63), when the primary case was unvaccinated, and VE(I) as 31% (95%-CI: 26-36), when the household contact was unvaccinated. Furthermore, unvaccinated secondary cases with an infection exhibited a three-fold higher viral load compared to fully vaccinated secondary cases with a breakthrough infection. Our results demonstrate that vaccinations reduce susceptibility to infection as well as infectiousness, which should be considered by policy makers when seeking to understand the public health impact of vaccination against transmission of SARS-CoV-2.